Australia has become the first country in the world to approve MDMA and psilocybin, the active ingredient in magic mushrooms, for medical treatment.
On Friday (February 3), the Therapeutic Goods Administration (TGA) announced that starting July 1 later this year, authorised psychiatrists will be able to prescribe MDMA for the treatment of post-traumatic stress disorder, and psilocybin to treat depression, Wired reports.
The news comes as a widening consensus builds among…